NALLPEN Drug Patent Profile
✉ Email this page to a colleague
When do Nallpen patents expire, and what generic alternatives are available?
Nallpen is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.
The generic ingredient in NALLPEN is nafcillin sodium. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nallpen
A generic version of NALLPEN was approved as nafcillin sodium by ISTITUTO BIO ITA SPA on April 20th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NALLPEN?
- What are the global sales for NALLPEN?
- What is Average Wholesale Price for NALLPEN?
Summary for NALLPEN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 32 |
| Patent Applications: | 1,220 |
| DailyMed Link: | NALLPEN at DailyMed |
US Patents and Regulatory Information for NALLPEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | NALLPEN | nafcillin sodium | INJECTABLE;INJECTION | 061999-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | NALLPEN IN PLASTIC CONTAINER | nafcillin sodium | INJECTABLE;INJECTION | 050655-002 | Oct 31, 1989 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | NALLPEN | nafcillin sodium | INJECTABLE;INJECTION | 062755-002 | Dec 19, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | NALLPEN IN PLASTIC CONTAINER | nafcillin sodium | INJECTABLE;INJECTION | 050655-001 | Oct 31, 1989 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | NALLPEN | nafcillin sodium | INJECTABLE;INJECTION | 062755-001 | Dec 19, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
